ID

34470

Beschrijving

Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00922129

Link

https://clinicaltrials.gov/show/NCT00922129

Trefwoorden

  1. 17-01-19 17-01-19 -
  2. 27-05-19 27-05-19 -
  3. 29-05-19 29-05-19 -
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

17 januari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Prostate Cancer NCT00922129

Eligibility Prostate Cancer NCT00922129

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
male patients ≤ 50 years in their post renal transplant follow-up;
Beschrijving

ID.1

Datatype

boolean

biopsy confirmed prostate cancer;
Beschrijving

ID.2

Datatype

boolean

stable renal function with gfr ≥ 40 ml/min.
Beschrijving

ID.3

Datatype

boolean

Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with metastatic disease;
Beschrijving

ID.4

Datatype

boolean

uncontrolled hyperlipidemia;
Beschrijving

ID.5

Datatype

boolean

proteinuria > 500 mg/day;
Beschrijving

ID.6

Datatype

boolean

biopsy evidence of acute rejection within the past 3 months;
Beschrijving

ID.7

Datatype

boolean

existence of any surgical or medical condition, other than the current transplant, which in the opinion of the investigator might significantly alter the absorption, distribution, metabolism or excretion of study medication;
Beschrijving

ID.8

Datatype

boolean

patients with mental illness;
Beschrijving

ID.9

Datatype

boolean

inability to cooperate or communicate with the investigator or unable to complete self administered questionnaires.
Beschrijving

ID.10

Datatype

boolean

Similar models

Eligibility Prostate Cancer NCT00922129

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male patients ≤ 50 years in their post renal transplant follow-up;
boolean
ID.2
Item
biopsy confirmed prostate cancer;
boolean
ID.3
Item
stable renal function with gfr ≥ 40 ml/min.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
patients with metastatic disease;
boolean
ID.5
Item
uncontrolled hyperlipidemia;
boolean
ID.6
Item
proteinuria > 500 mg/day;
boolean
ID.7
Item
biopsy evidence of acute rejection within the past 3 months;
boolean
ID.8
Item
existence of any surgical or medical condition, other than the current transplant, which in the opinion of the investigator might significantly alter the absorption, distribution, metabolism or excretion of study medication;
boolean
ID.9
Item
patients with mental illness;
boolean
ID.10
Item
inability to cooperate or communicate with the investigator or unable to complete self administered questionnaires.
boolean

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial